GHK-Cu
Also known as: Copper Peptide
A naturally occurring copper-binding peptide found throughout the body; levels drop after age 20. The most studied cosmetic peptide, with proven effects on collagen production, skin renewal, wound healing, and antioxidant protection. It influences over 4,000 genes, shifting them toward a younger, more regenerative pattern. People use it for skin aging, wound healing, and anti-aging.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide bound to a copper ion that was first identified in human plasma in 1973. It is one of the most extensively studied peptides in skin science and wound healing, with research spanning five decades. Blood levels of GHK-Cu decline significantly with age — roughly 60% reduction by age 60 — which correlates with reduced healing capacity and skin aging.
GHK-Cu's biological activity is remarkably broad. It has been shown to activate over 4,000 genes involved in tissue remodeling, switching gene expression patterns from a damaged state to a healthy repair state. Key effects include stimulation of collagen and elastin synthesis, upregulation of antioxidant enzymes (SOD, glutathione), promotion of blood vessel growth, attraction of immune cells to wound sites, and inhibition of metalloproteinases that break down the extracellular matrix.
GHK-Cu is available in multiple formulations: topical serums and creams (the most common and safest route), injectable subcutaneous formulations, and microneedling applications. For skin rejuvenation, topical concentrations of 1-2% applied once or twice daily have shown measurable improvements in wrinkle depth, skin elasticity, and collagen density in clinical studies. It is considered one of the safest peptides with the strongest evidence for skin-specific anti-aging benefits.
Dosage
Topical: 1-2% serum 1-2x daily. Injectable: 1-2 mg subcutaneous daily
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Administration
Topical (serums, creams), subcutaneous injection, or microneedling
Get Research-Grade GHK-Cu
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Effects
Skin Rejuvenation
Stimulates collagen I/III synthesis, improves density, firmness, and elasticity.
Gene Regulation
Modulates expression of 4,000+ genes toward a younger regenerative profile.
Wound Healing
Copper delivery activates lysyl oxidase for proper collagen cross-linking.
Antioxidant
Copper delivery to SOD enzyme provides oxidative stress protection.
Mechanism of Action
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide first isolated from human plasma in 1973 by Dr. Loren Pickart. Its copper-binding affinity is exceptionally high, and this copper chelation is central to its biological activity — the copper ion is coordinated by the histidine and lysine residues, creating a stable yet bioavailable copper delivery system.
The primary mechanism involves activation of copper-dependent enzymes critical for tissue structure and defense. Lysyl oxidase requires copper to catalyze the oxidative deamination of lysine and hydroxylysine residues in collagen and elastin precursors, forming the covalent cross-links (desmosine and isodesmosine) that give connective tissue its tensile strength and elasticity. Without adequate copper delivery, collagen fibers remain weak and poorly organized. Superoxide dismutase (Cu/Zn-SOD) uses the copper delivered by GHK-Cu for its antioxidant catalytic cycle, converting destructive superoxide radicals into hydrogen peroxide and oxygen.
Beyond copper delivery, GHK-Cu has remarkable gene-regulatory effects. Transcriptomic studies have shown it modulates the expression of over 4,000 human genes — approximately 6% of the genome. It upregulates genes involved in collagen synthesis (types I, III, V), elastin production, glycosaminoglycan synthesis, integrin and laminin expression, and growth factor production (TGF-β, VEGF, FGF). Simultaneously, it downregulates genes associated with inflammation, tissue destruction (matrix metalloproteinases), and fibrosis. In skin specifically, GHK-Cu stimulates dermal fibroblast proliferation, increases dermal thickness, improves skin density and firmness, and enhances wound contraction. It also promotes nerve outgrowth and blood vessel formation at wound sites. The breadth of its gene-regulatory activity suggests it acts as a master signaling molecule for tissue remodeling, essentially resetting gene expression patterns toward a younger, more regenerative profile.
Regulatory Status
Topical: widely available as cosmetics (not regulated as drugs). Injectable: not FDA approved. GRAS in cosmetic concentrations.
Risks & Safety
Common
mild skin irritation, redness, bruising, injection site irritation.
Serious
theoretical risk of copper accumulation with long-term high doses; no long-term safety data for injectable use.
Rare
allergic reactions, contact dermatitis.
Compare GHK-Cu With
Research Papers
27Published: December 31, 2025
AI Summary
Emerging wound-healing strategies combine scaffolds, growth factors, and peptides like GHK-Cu with smart dressings that monitor and treat wounds. The review covers orthopedic applications and the challenge of cartilage repair.
Published: December 31, 2025
AI Summary
Peptides such as GHK-Cu support wound healing and tissue repair, while growth hormone secretagogues promote muscle recovery. The review outlines their mechanisms and the need for more clinical evidence in orthopedics.
Published: December 31, 2025
AI Summary
Therapeutic peptides are increasingly used for orthopedic injuries. The review summarizes current evidence to help surgeons understand what these compounds can and cannot do.
Published: December 24, 2025
AI Summary
An injectable filler made of hydroxyapatite microspheres loaded with GHK-Cu reduced inflammation and oxidative stress in lab models. The combination may improve outcomes for soft tissue fillers.
Published: April 15, 2025
AI Summary
Conjugating GHK with hyaluronic acid and copper improved bone and blood vessel growth in lab tests. Copper helped activate protective and regenerative pathways in cells.
Published: March 11, 2025
AI Summary
Peptide-gold nanoparticle hybrids with GHK improved wound healing and cancer cell killing under near-infrared light. The approach may support both tissue repair and cancer therapy.
Published: April 27, 2025
AI Summary
GHK is widely used in anti-wrinkle products for its collagen and skin repair effects, but data on skin penetration and effectiveness of GHK-Cu and Pal-GHK remain limited.
Published: February 2, 2025
AI Summary
A hydrogel made from konjac and egg white loaded with GHK-Cu promoted wound healing and blood vessel growth in lab tests. The food-derived dressing may offer a low-cost option for infected wounds.
Published: December 31, 2024
AI Summary
GHK-Cu is hydrophilic and poorly absorbed through skin barriers. The review discusses how liposomes might improve its delivery and the methods needed to measure skin permeation.
Published: January 27, 2025
AI Summary
A combination of palmitoyl copper peptide and acetyl tyrosine increased melanin production in melanoma cell lines. The finding may inform skin care or pigmentation research.
Published: November 24, 2024
AI Summary
Capillary electrophoresis coupled to mass spectrometry was used to monitor GHK-Cu encapsulation in liposomes for cosmetic formulations. The technique may help optimize liposomal delivery.
Published: September 13, 2024
AI Summary
GHK-Cu reduced lung inflammation and fibrosis in a mouse silicosis model by targeting a protein involved in oxidative stress. The peptide may offer a treatment for silica-related lung disease.
Published: May 1, 2024
AI Summary
GHK prevented copper- and zinc-induced protein clumping and cell death in brain cells. The peptide may support research into neurodegenerative diseases linked to metal toxicity.
Published: April 29, 2024
AI Summary
A liposome-based carrier for GHK-Cu improved antioxidant and anti-inflammatory effects in skin cells. The system slowed peptide release and protected against degradation.
Published: January 11, 2024
AI Summary
A GHK-like peptide reduced inflammation and sped wound healing in rats. The peptide increased fibroblast and macrophage activity while reducing granulocytes.
Published: September 29, 2024
AI Summary
Intranasal GHK-Cu delayed cognitive decline, reduced amyloid plaques, and lowered inflammation in a mouse model of Alzheimer's. The peptide may warrant further study as a potential AD treatment.
Published: November 20, 2023
AI Summary
Intranasal GHK-Cu delayed cognitive decline, reduced amyloid plaques, and lowered inflammation in a mouse model of Alzheimer's. The peptide may warrant further study as a potential AD treatment.
Published: January 31, 2024
AI Summary
An ionic liquid microemulsion improved skin delivery of GHK-Cu by about threefold and promoted hair growth in mice. The system may offer a non-invasive option for hair loss.
Published: November 16, 2023
AI Summary
Intranasal GHK-Cu improved spatial memory and learning in aged mice and reduced markers of brain inflammation. The peptide may help protect against age-related cognitive decline.
Published: October 17, 2023
AI Summary
Liposomes loaded with GHK-Cu inhibited elastase and showed promise for skin delivery. The formulation may support anti-aging and wound-healing applications.
Published: September 11, 2023
AI Summary
GHK-modified nanochannels enabled ultrasensitive detection of copper ions in water. The system could be regenerated and reused for environmental monitoring.
Published: August 28, 2023
AI Summary
GHK-Cu reduced airway remodeling in asthmatic mice by activating SIRT1. People with asthma had lower plasma GHK, suggesting a possible role in disease.
Published: September 15, 2023
AI Summary
The study examined whether GHK-Cu and hyaluronic acid together increase collagen IV production in skin cells.
Published: August 1, 2022
AI Summary
A hydrogel with GHK-functionalized nanofibers promoted blood vessel growth and wound healing in diabetic mice. The scaffold may support diabetic wound healing.
Published: July 25, 2022
AI Summary
A polymer gel loaded with GHK-Cu released the peptide over time and improved wound closure in animal tests. The material showed promise for controlled peptide delivery.
Published: March 31, 2021
AI Summary
A tripeptide and hexapeptide formulation improved healing and skin rejuvenation after resurfacing and cryolipolysis. The review summarizes evidence for these skincare ingredients.
Published: April 12, 2021
AI Summary
A peptide mixture including GHK protected skin fibroblasts from hydrogen peroxide-induced aging. The combination increased antioxidant enzymes and collagen content.
Frequently Asked Questions
What is GHK-Cu?
A naturally occurring copper-binding peptide found throughout the body; levels drop after age 20. The most studied cosmetic peptide, with proven effects on collagen production, skin renewal, wound healing, and antioxidant protection. It influences over 4,000 genes, shifting them toward a younger, more regenerative pattern. People use it for skin aging, wound healing, and anti-aging.
What is GHK-Cu used for?
A naturally occurring copper-binding peptide found throughout the body; levels drop after age 20. The most studied cosmetic peptide, with proven effects on collagen production, skin renewal, wound healing, and antioxidant protection. It influences over 4,000 genes, shifting them toward a younger, more regenerative pattern. People use it for skin aging, wound healing, and anti-aging.
What is the dosage for GHK-Cu?
Topical: 1-2% serum or cream once or twice daily. Injectable: 1-2 mg subcutaneous once daily. Microneedling: applied topically immediately after microneedling for enhanced penetration. Typical courses run 4-12 weeks.
What are the side effects of GHK-Cu?
Common: mild skin irritation, redness, bruising, injection site irritation. Serious: theoretical risk of copper accumulation with long-term high doses; no long-term safety data for injectable use. Rare: allergic reactions, contact dermatitis.
How does GHK-Cu work?
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide first isolated from human plasma in 1973 by Dr. Loren Pickart. Its copper-binding affinity is exceptionally high, and this copper chelation is central to its biological activity — the copper ion is coordinated by the histidine and lysine residues, creating a stable yet bioavailable copper delivery system. The primary mechanism involves activation of copper-dependent enzymes critical for tissue structure and defense. Lysyl oxidase requires copper to catalyze the oxidative deamination of lysine and hydroxylysine residues in collagen and elastin precursors, forming the covalent cross-links (desmosine and isodesmosine) that give connective tissue its tensile strength and elasticity. Without adequate copper delivery, collagen fibers remain weak and poorly organized. Superoxide dismutase (Cu/Zn-SOD) uses the copper delivered by GHK-Cu for its antioxidant catalytic cycle, converting destructive superoxide radicals into hydrogen peroxide and oxygen. Beyond copper delivery, GHK-Cu has remarkable gene-regulatory effects. Transcriptomic studies have shown it modulates the expression of over 4,000 human genes — approximately 6% of the genome. It upregulates genes involved in collagen synthesis (types I, III, V), elastin production, glycosaminoglycan synthesis, integrin and laminin expression, and growth factor production (TGF-β, VEGF, FGF). Simultaneously, it downregulates genes associated with inflammation, tissue destruction (matrix metalloproteinases), and fibrosis. In skin specifically, GHK-Cu stimulates dermal fibroblast proliferation, increases dermal thickness, improves skin density and firmness, and enhances wound contraction. It also promotes nerve outgrowth and blood vessel formation at wound sites. The breadth of its gene-regulatory activity suggests it acts as a master signaling molecule for tissue remodeling, essentially resetting gene expression patterns toward a younger, more regenerative profile.
How is GHK-Cu administered?
GHK-Cu is administered via topical (serums, creams), subcutaneous injection, or microneedling.
What is the half-life of GHK-Cu?
The half-life of GHK-Cu is Topical: variable (local effect) | Injectable: 1-2 hours.
Is GHK-Cu legal?
Topical: widely available as cosmetics (not regulated as drugs). Injectable: not FDA approved. GRAS in cosmetic concentrations.
Related Peptides
AEDG Peptide
A tetrapeptide (Ala-Glu-Asp-Gly) identical to Epithalon's core active sequence — effectively the same compound. Studied for telomerase activation and pineal gland regulation, promoting melatonin production and potentially slowing cellular aging through telomere maintenance. Part of the Khavinson bioregulator peptide family developed in St. Petersburg.
Ara-290
A peptide derived from EPO (the hormone that boosts red blood cells) but engineered to keep only the tissue-protective effects — it doesn't increase red blood cells at all. It activates the body's repair receptors to protect tissues and regenerate nerves. Particularly promising for nerve damage and tissue injury from poor blood flow. People use it for diabetic nerve damage and similar conditions.
Botulinum Toxin
A toxin produced by bacteria — the most potent biological toxin known, yet one of the most widely used cosmetic and medical treatments globally. In carefully controlled doses, it temporarily relaxes targeted muscles by blocking the signal that tells muscles to contract. Approved for cosmetic wrinkle reduction and many medical conditions including chronic migraine, excessive sweating, and neck muscle spasms. People use it for forehead lines, crow's feet, frown lines, and various medical conditions.
BPC-157
A healing compound made from a protein found in stomach fluid. It's the most studied peptide for tissue repair, with research showing it helps heal tendons, ligaments, muscles, the gut, and other organs. It's stable enough to survive stomach acid, so you can take it either by injection under the skin or by mouth.